Neuroleptic drugs cause many forms of extra-pyramidal syndromes. One of these, tardive dyskinesia,1 occurs only after the patient has been taking the drug for some time ('tardive' refers to the late onset). The movements are involuntary and repetitive usually involving the face and tongue, but...
DrugsDrug-Induced Dyskinesia,Part 1:Treatment of Levodopa-Induced Dyskinesia. Vijayakumar D,Jankovic J. Drugs . 2016Vijayakumar, D., and Jankovic, J. (2016). Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia. Drugs 76, 759-777. doi: 10.1007/s40265-016-0566-3...
Another factor responsible for driving the demand for tardive dyskinesia therapeutics is the growing consumption ofantipsychotic drugsfor the treatment of psychotic disorders. Antipsychotic drugs are commonly prescribed for schizophrenia, attention-deficit hyperactivity disorder (ADHD), epilepsy, and dementia, ...
1.2 Administration of Drugs Opiold antagonists, or vehicle, were administered with L-DOPA to assess the effects of adjunctive treatment on L-DOPA-induced dyskinesia and the anti-parkinsonian efficacy of L-DOPA. All animals received all treatments. Treatments in any one animal were separated by ...
Casey DE, Gerlach J (1984) Tardive dyskinesia: management and new treatment. In: Stancer HC, Garflnkel PE, Rakoff VM (eds) Guidelines for the use of psychotropic drugs. Spectrum, New York, pp 183–203Casey DE, Gerlach J: Tardive dyskinesia: Management and new treat- ment, chap 12, ...
Antidepressants are drugs used to treat depression. The best and most commonly used drug for the treatment of depression is selective serotonin reuptake inhibitors (SSRIs). Mental Health: Where to Get Mental Health Help When you think of mental health, lying on a couch in a therapist’s office...
Comparison of treatment pricing, U.S. Typical U.S. commercial payer coverage Despite support programs, existing TD drugs still have barriers to access Resources offered by Teva and Neurocrine to help facilitate patient access ...
Muller T. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Expert opinion on investigational drugs. 2015;24(6):737–42 (Epub 2015/03/27) .Ondo WG, Hanna PA, Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J...
The state-of-art therapeutic approaches with available molecular agents, including optimization ofL-Dopa and DA-agonist treatment strategies in order to minimize the shift towards nonpulsatile control of clinical signs; ongoing utilization of nondopaminergic drugs with consistent experimental evidence of pot...
Dopamine receptor blocking drugs, commonly used in the treatment of involuntary movements, may cause potentially serious adverse effects, including tardive... J Jankovic,J Orman - 《Neurology》 被引量: 357发表: 1988年 Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of th...